{
    "2018-06-22": [
        [
            {
                "time": "2023-10-18",
                "original_text": "Is AbbVie Inc (NYSE:ABBV) A Buy At Its Current PE Ratio?",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "PE Ratio",
                        "Buy"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "Top Research Reports for Procter & Gamble, AbbVie & IBM",
                "features": {
                    "keywords": [
                        "Research Reports",
                        "Procter & Gamble",
                        "AbbVie",
                        "IBM"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "consumer goods",
                        "healthcare",
                        "technology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}